ProfileGDS4132 / 201783_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 65% 85% 87% 86% 86% 85% 88% 80% 87% 83% 78% 90% 89% 89% 89% 90% 89% 91% 90% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101186.20665
GSM201543Muscle PCOS pioglitazone 121302.00285
GSM201544Muscle PCOS pioglitazone 161387.6787
GSM201545Muscle PCOS pioglitazone 201382.86286
GSM201829Muscle PCOS pioglitazone 231361.02386
GSM201830Muscle PCOS pioglitazon 251334.16785
GSM201831Muscle PCOS pioglitazone 271377.94588
GSM201832Muscle PCOS pioglitazone 31262.3880
GSM201833Muscle PCOS pioglitazone 41364.74387
GSM201834Muscle PCOS pioglitazone 81320.72483
GSM201835Muscle PCOS after pioglitazone 102255.03178
GSM201836Muscle PCOS after pioglitazone 122464.1890
GSM201837Muscle PCOS after pioglitazone 162415.3889
GSM201838Muscle PCOS after pioglitazone 202443.93789
GSM201839Muscle PCOS after pioglitazone 232435.1189
GSM201840Muscle PCOS after pioglitazone 252491.19490
GSM201841Muscle PCOS after pioglitazone 272405.54289
GSM201842Muscle PCOS after pioglitazone 32476.24991
GSM201843Muscle PCOS after pioglitazone 42468.93290
GSM201844Muscle PCOS after pioglitazone 82344.83885